Previous close | 24.65 |
Open | 24.70 |
Bid | 24.48 x 0 |
Ask | 24.51 x 0 |
Day's range | 24.39 - 24.73 |
52-week range | 23.65 - 37.50 |
Volume | |
Avg. volume | 97,867 |
Market cap | 138.703B |
Beta (5Y monthly) | 0.57 |
PE ratio (TTM) | 69.83 |
EPS (TTM) | 0.35 |
Earnings date | 01 May 2024 |
Forward dividend & yield | 1.56 (6.31%) |
Ex-dividend date | 25 Jan 2024 |
1y target est | N/A |
NEW YORK, April 24, 2024--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company’s common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The second-quarter 2024 cash dividend will be the 342nd consecutive quarterly dividend paid by Pfizer.
Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.